Antibody finds, wipes out prostate cancer: study
December 28, 2009US researchers have found an antibody that hunts down prostate cancer cells in mice and can destroy the killer disease even in an advanced stage, a study showed Monday.
The antibody, called F77, was found to bond more readily with cancerous prostate tissues and cells than with benign tissue and cells, and to promote the death of cancerous tissue, said the study published in the Proceedings of the National Academy of Science (PNAS).
When injected in mice, F77 bonded with tissue where prostate cancer was the primary cancer in almost all cases (97 percent) and in tissue cores where the cancer had metastasized around 85 percent of the time.
It recognized even androgen-independent cancer cells, present when prostate cancer is incurable, the study by researchers at the University of Pennsylvania showed.
F77 "initiated direct cell death of prostate cancer cells... and effectively prevented tumor outgrowth," it said.
But it did not target normal tissue, or tumor tissues in other parts of the body including the colon, kidney, cervix, pancreas, lung, skin or bladder, the study showed.
The antibody "shows promising potential for diagnosis and treatment of prostate cancer, especially for androgen-independent metastatic prostate cancer," which often spreads to the bones and is difficult to treat, the researchers wrote in PNAS.
Currently, the five-year survival rate for metastatic prostate cancer is just 34 percent, according to the study.
Prostate cancer is the second most common cancer among men, claiming half a million lives each year worldwide, according to the World Health Organisation (WHO).
(c) 2009 AFP
-
New treatment hope for prostate cancer
Feb 06, 2009 |
not rated yet |
0
-
New androgen prostate cancer pathway found
Nov 08, 2006 |
not rated yet |
0
-
Scientists find protein potential drug target for treatment-resistant prostate cancer
Dec 31, 2007 |
not rated yet |
0
-
Blocking signaling protein prevents prostate cancer spread
Jun 02, 2008 |
not rated yet |
0
-
Radiation added to hormone therapy increases survival for men with prostate cancer
Sep 22, 2008 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (29) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
4 / 5 (22) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Exercise and weight loss
1 hour ago
-
Why do we have head aches? Our brains can't feel anything.
5 hours ago
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
-
Lowe syndrom genetic test
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
New study: Adolescents suffering from depression more likely to be bullied
A new study provides evidence that adolescents who suffer from depression are more likely to develop difficulty in peer relationships including being bullied at school.
Medicine & Health / Psychology & Psychiatry
11 minutes ago |
not rated yet |
0
Playing school sports affects youths' smoking
Young people's choices about using drugs and alcohol are influenced by peersnot only close friends, but also sports teammates. A new study of middle schoolers and their social networks has found that teammates' smoking ...
13 minutes ago |
not rated yet |
0
Rothman at Jefferson research suggests abandon convention in diagnosing periprosthetic joint infection
In their search for new, better ways to diagnose periprosthetic joint infection, Rothman Institute at Jefferson researchers have discovered that measurement of C-reactive protein in the synovial fluid is extremely accurate, ...
2 minutes ago |
not rated yet |
0
High-quality child care found good for children -- and their mothers
High-quality early child care isn't important just for children, but for their mothers, too. That's the conclusion of a new study by researchers at the University of Texas at Austin; the study appears in the journal Child De ...
12 minutes ago |
not rated yet |
0
Green tea found to reduce disability in the elderly
(Medical Xpress) -- A lot of research has been done over the past several years looking into the health benefits of green tea. As a result, scientists have found that regular consumption of the beverage leads ...
Scared of a younger rival? Not for some male songbirds
When mature male white-crowned sparrows duel to win a mate or a nesting territory, a young bird just doesn't get much respect.
Preventing bacteria from falling in with the wrong crowd could help stop gum disease
Stripping some mouth bacteria of their access key to gangs of other pathogenic oral bacteria could help prevent gum disease and tooth loss. The study, published in the journal Microbiology suggests that t ...
New study sheds light on genetics of rice metabolism
A large-scale study analyzing metabolic compounds in rice grains conducted by researchers at the RIKEN Plant Science Center (PSC) and their collaborators has identified 131 rice metabolites and clarified the ...
Scientists develop biological computer to encrypt and decipher images
Scientists at The Scripps Research Institute in California and the TechnionIsrael Institute of Technology have developed a "biological computer" made entirely from biomolecules that is capable of deciphering ...
Mars-bound NASA rover carries coin for camera checkup
(PhysOrg.com) -- The camera at the end of the robotic arm on NASA's Mars rover Curiosity has its own calibration target, a smartphone-size plaque that looks like an eye chart supplemented with color chips ...
Entire genome of extinct human decoded from fossil
(PhysOrg.com) -- In 2010, Svante Pääbo and his colleagues presented a draft version of the genome from a small fragment of a human finger bone discovered in Denisova Cave in southern Siberia. The ...
Dec 28, 2009
Rank: 5 / 5 (1)
Dec 29, 2009
Rank: 5 / 5 (1)
Dec 29, 2009
Rank: 5 / 5 (1)
The drug is useless if it 'cures' the cancer but kills from some other effect.
Dec 29, 2009
Rank: 4 / 5 (1)
Dec 30, 2009
Rank: 2 / 5 (2)
Dec 30, 2009
Rank: 4 / 5 (4)
Dec 30, 2009
Rank: 5 / 5 (2)
Dec 30, 2009
Rank: 5 / 5 (1)
Dec 30, 2009
Rank: 3 / 5 (1)
Obviously you will have to sign that you take full responsibility for any results.
Dec 30, 2009
Rank: 5 / 5 (2)
Rushing things into usage can have horrible consequences.
Dec 30, 2009
Rank: not rated yet
For example, it says:
Note theat it gives the survival rate for METASTATIC prostate cancer and in the next sentence describes the occurence rate for ALL prostrate cancers. They follow it with the death rate from what is presumably the metastatic cancer, since regular prostrate cancer isn't deadly, but by that sentence most men are already unnecessarily worried. This is disingenuous and misleading, many men with prostrate cancer don't need treatment and most of the ones who do need it for LOCAL secondary symptoms like difficulty in urination, etc.
Dec 30, 2009
Rank: 5 / 5 (2)
What we are telling patients is: "We have a cure for your terminal illness, but it MIGHT kill you. We cannot afford the risk to our . . . "
Dec 30, 2009
Rank: 3.5 / 5 (2)
I agree with you. However, no contract, no matter how well explained and how clearly written and ironclad will escape the Doctor, hospital and drug manufacturer from getting sued and possibly losing a huge lawsuit. And even if they win the lawsuit, the expense in both money and community good will would be onerous. I blame this entirely on medical malpractice lawyers getting rich on settlements for cases which shouldn't have been made. Tort reform would help here, but will probably never happen.
Dec 30, 2009
Rank: not rated yet
Maybe PhysOrg could do a section where they tell us about theories and trials that actually have been released for public consumption?
Dec 30, 2009
Rank: not rated yet
Dec 31, 2009
Rank: not rated yet
Agreed. Many commenters are seemingly confusing an antibody with a chemical drug. An antibody is essentially a 'tag' that tells your own body's white blood cells: "kill this". Obviously it's important that that antibody doesn't cause your autoimmune system to start going nuts and destroying your healthy tissues, but we're not looking at the same questionable side-effects of a chemical drug or radiation treatment.
Dec 31, 2009
Rank: 1 / 5 (1)
Methinks that using the dying to test for possible beneficial effects of drugs and treatments is morallly a shakey proposition.
Dec 31, 2009
Rank: 5 / 5 (2)
Methinks that most of the dying would wish to attempt anything to extend their lives or to prevent others from suffering their pain and eventual death when it was possibly preventable.
Dec 31, 2009
Rank: 5 / 5 (1)
Seconded.
Dec 31, 2009
Rank: 5 / 5 (1)
I was curious why the cervix was mentioned for MALE patients ?!? Did I miss something in biology??
Jan 01, 2010
Rank: not rated yet
First what if there is no curative effect and the effect of the drug is to increase suffering ten fold? (as in maybe an even more unpleasant death)
Another consideration - at the early stages of drug development, the cost for dosages are extremely high. Think of buying a car vs a "concept car". Now consider the case of the "concept car" built at a very small scale (analogy: dosage amounts for mice). Now it needs to be built to fit a person and still work properly (scaling up the chemistry to larger amounts is often not trivial)
Now who will pay for the treatment that might turn out to be ineffectual? We're not talking $1000/per dose here - likely much much more - solvents, reagents, researcher's time to produce the drug are all expensive.
Jan 02, 2010
Rank: not rated yet